These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27723887)

  • 1. Innovation-Innovation Tradeoffs in Drug Pricing.
    Sachs RE; Frakt AB
    Ann Intern Med; 2016 Dec; 165(12):871-872. PubMed ID: 27723887
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical research: cost savings through innovation.
    Cohen KR; Levy RA
    AAPPO J; 1993 Oct; 3(5):28-36. PubMed ID: 10146463
    [No Abstract]   [Full Text] [Related]  

  • 3. Pricing of pharmaceuticals is becoming a major challenge for health systems.
    Morgan SG; Bathula HS; Moon S
    BMJ; 2020 Jan; 368():l4627. PubMed ID: 31932289
    [No Abstract]   [Full Text] [Related]  

  • 4. Defining the concept of fair pricing for medicines.
    Moon S; Mariat S; Kamae I; Pedersen HB
    BMJ; 2020 Jan; 368():l4726. PubMed ID: 31932334
    [No Abstract]   [Full Text] [Related]  

  • 5. Can affordability and innovation coexist for medicines?
    Colbert A; Rintoul A; Simão M; Hill S; Swaminathan S
    BMJ; 2020 Jan; 368():l7058. PubMed ID: 31932276
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients not patents: Drug research and development as a public enterprise.
    Gøtzsche PC
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29243246
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of COVID-19 on pharmaceutical external innovation sourcing.
    Robke L; Berghauser Pont L; Bongard J; Wurzer S; Smietana K; Moss R
    Nat Rev Drug Discov; 2020 Dec; 19(12):829. PubMed ID: 33173230
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmaceutical industry--prices and progress.
    Scherer FM
    N Engl J Med; 2004 Aug; 351(9):927-32. PubMed ID: 15329432
    [No Abstract]   [Full Text] [Related]  

  • 9. Notable deals in the pharmaceutical industry in the fourth quarter of 2016.
    D'Souza P
    Drugs Today (Barc); 2017 Jan; 53(1):75-82. PubMed ID: 28387386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA chief wants other rich countries to share drug development costs.
    Hopkins Tanne J
    BMJ; 2003 Oct; 327(7419):830. PubMed ID: 14551076
    [No Abstract]   [Full Text] [Related]  

  • 11. Tying Medicare Part B Drug Prices to International Reference Pricing Will Devastate R&D.
    Schulthess D; Gassull D; Maisel S
    Ther Innov Regul Sci; 2019 Nov; 53(6):746-751. PubMed ID: 31771361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.
    Outterson K; Gopinathan U; Clift C; So AD; Morel CM; Røttingen JA
    PLoS Med; 2016 Jun; 13(6):e1002043. PubMed ID: 27299990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future research agenda. A view from the pharmaceutical industry.
    Barr C
    Pharmacoeconomics; 1994; 6 Suppl 1():61-2. PubMed ID: 10155587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current challenges for the pharmaceutical research industry].
    Chalchat B
    Ann Pharm Fr; 1993; 51(1):16-25. PubMed ID: 8215118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canada's New Generic Pricing Policy: A Reasoned Approach to a Challenging Problem.
    Hollis A; Grootendorst P
    Healthc Policy; 2015 Aug; 11(1):10-4. PubMed ID: 26571465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline in economic returns from new drugs raises questions about sustaining innovations.
    Berndt ER; Nass D; Kleinrock M; Aitken M
    Health Aff (Millwood); 2015 Feb; 34(2):245-52. PubMed ID: 25646104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From the molecule to the drug: innovation or distribution].
    Ménard HA
    Union Med Can; 1993; 122(1):4. PubMed ID: 8465475
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical research and development spending Ranked by percentage of revenue spent on research in 2015 ($ in millions).
    Mod Healthc; 2016 Oct; 46(41):35. PubMed ID: 30398790
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescription drug pricing: the consumer perspective.
    Searing A
    N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence Europe 2017. London, UK - February 22-23, 2017.
    Kibble A
    Drugs Today (Barc); 2017 Mar; 53(3):203-207. PubMed ID: 28447077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.